StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
101
This year
1
Publishing Date
2023 - 02 - 10
3
2022 - 11 - 08
2
2022 - 09 - 15
1
2022 - 09 - 09
1
2022 - 08 - 22
1
2022 - 08 - 16
1
2022 - 06 - 27
1
2022 - 06 - 23
1
2022 - 06 - 22
1
2022 - 06 - 07
1
2022 - 05 - 23
1
2022 - 04 - 14
1
2022 - 04 - 06
1
2022 - 03 - 23
1
2022 - 03 - 18
1
2022 - 03 - 08
1
2022 - 02 - 22
1
2022 - 02 - 16
1
2022 - 02 - 10
1
2022 - 01 - 21
1
2021 - 12 - 24
1
2021 - 12 - 10
1
2021 - 12 - 09
1
2021 - 12 - 01
1
2021 - 11 - 22
1
2021 - 11 - 18
1
2021 - 11 - 09
1
2021 - 11 - 08
1
2021 - 10 - 29
1
2021 - 10 - 20
1
2021 - 10 - 06
1
2021 - 09 - 21
1
2021 - 09 - 01
1
2021 - 08 - 24
1
2021 - 08 - 19
2
2021 - 08 - 09
1
2021 - 08 - 04
1
2021 - 08 - 03
1
2021 - 07 - 29
1
2021 - 07 - 21
1
2021 - 07 - 20
1
2021 - 07 - 19
1
2021 - 07 - 06
1
2021 - 06 - 28
1
2021 - 06 - 22
1
2021 - 06 - 09
1
2021 - 06 - 03
1
2021 - 05 - 05
1
2021 - 04 - 28
1
2021 - 04 - 21
1
2021 - 04 - 14
1
2021 - 04 - 07
1
2021 - 03 - 22
1
2021 - 02 - 23
1
2021 - 02 - 03
1
2021 - 02 - 02
1
2021 - 01 - 04
1
2020 - 12 - 31
1
2020 - 12 - 14
1
2020 - 12 - 10
1
Sector
Commercial services
2
Consumer non-durables
1
Consumer services
1
Distribution services
1
Electronic technology
1
Finance
2
Health services
101
Health technology
36
Information
2
Manufacturing
10
N/a
2
Professional, scientific, and technical services
2
Technology services
7
Tags
Acquisition
1
Africa
1
Agreement
2
Asco
1
Biomarkers
5
Biotech-beach
24
Brain cancer
2
Breast
2
Breast cancer
4
Business
1
Cancer
31
Care
1
Collaboration
3
Commercialization
2
Companies
2
Conference
12
Covid
6
Covid-19
6
Diagnostic
11
Diagnostics
16
Earnings
4
Events
6
Financial
6
Financial results
5
Genetic
3
Global
9
Grant
3
Granted
3
Growth
8
Her2
2
Her2-
2
Ipo
3
Lung cancer
4
Market
20
Metastatic breast cancer
3
Molecular
2
Money
2
N/a
36
Nasdaq
2
Offering
2
People
5
Plus
2
Potential
2
Presentation
2
Product-news
2
Rare
4
Reach
2
Report
15
Research
17
Results
12
System
4
Technology
3
Test
9
Therapeutics
3
Today
2
Train
4
Treatment
2
Trial
3
Tumor
2
Tumor cells
4
Entities
10x genomics, inc.
6
Abbott laboratories
7
Accelerate diagnostics, inc.
2
Acer therapeutics inc.
1
Adaptive biotechnologies corporation
1
Agilent technologies, inc.
1
Akumin inc.
1
American assets trust, inc.
1
Angle plc
9
Applied dna sciences, inc.
1
Becton, dickinson and company
13
Bio-rad laboratories, inc.
10
Bio-techne corp
6
Biocept, inc.
101
Boston scientific corporation
3
Cardinal health, inc.
1
Caredx, inc.
2
Castle biosciences, inc.
5
Conmed corporation
2
Dermtech, inc.
1
Exact sciences corporation
3
Financial strategies acquisition corp.
1
Genesis growth tech acquisition corp.
1
Genetic technologies ltd
1
Guardant health, inc.
8
Hologic, inc.
1
Icon plc
3
Illumina, inc.
9
Infinity pharmaceuticals, inc.
1
Invitae corporation
9
Johnson & johnson
1
Kiromic biopharma, inc.
1
Koninklijke philips n.v.
1
Laboratory corporation of america holdings
1
Liberty tripadvisor holdings, inc.
1
Medicenna therapeutics corp.
1
Medtronic plc
2
Mesa laboratories, inc.
4
Myriad genetics, inc.
6
Nanthealth, inc.
7
Nasdaq, inc.
1
Natera, inc.
3
Neogenomics, inc.
2
Nvidia corporation
1
Ontrak, inc.
1
Orthopediatrics corp.
1
Perkinelmer, inc.
2
Plus therapeutics, inc.
2
Precipio, inc.
1
Presidio property trust, inc.
1
Qiagen n.v.
1
Quest diagnostics incorporated
3
Rennova health, inc.
2
Ricebran technologies
1
Rvl pharmaceuticals plc
1
Shift technologies, inc.
1
Stryker corporation
1
Thermo fisher scientific inc
14
Trinity biotech plc
2
Veracyte, inc.
1
Symbols
A
36
ABT
81
AMED
69
AMEH
51
AMS
73
AMZN
35
APTX
60
AWRE
57
BDSX
78
BDX
52
BIO
43
BIOC
101
BKD
47
BNR
66
CI
124
CNC
306
CRDF
67
DGX
200
DVA
94
EHC
88
ENSG
56
EPWCF
45
FLGT
82
FMCQF
60
GH
116
GHSI
35
ICLR
53
ILMN
67
IQV
119
JNJ
38
JYNT
53
LH
283
LHCG
99
MDT
39
MS
44
NEO
127
NHC
62
NRC
96
NTRA
205
NVTA
143
ONCS
37
OPCH
57
OPTN
93
PHG
34
PINC
82
PLX
65
PMD
35
PNTG
47
QGEN
35
RDNT
94
SDC
58
SGRY
50
SMTI
48
SYNH
141
TDOC
109
TMO
105
UHS
92
USPH
34
VMD
37
XGN
73
Exchanges
Nasdaq
101
Nyse
29
Crawled Date
2023 - 02 - 10
3
2022 - 11 - 08
2
2022 - 09 - 15
1
2022 - 09 - 09
1
2022 - 08 - 23
1
2022 - 08 - 16
1
2022 - 06 - 27
1
2022 - 06 - 23
1
2022 - 06 - 22
1
2022 - 06 - 07
1
2022 - 05 - 23
1
2022 - 04 - 14
1
2022 - 04 - 06
1
2022 - 03 - 23
1
2022 - 03 - 18
1
2022 - 03 - 08
1
2022 - 02 - 22
1
2022 - 02 - 16
1
2022 - 02 - 10
1
2022 - 01 - 21
1
2021 - 12 - 24
1
2021 - 12 - 10
1
2021 - 12 - 09
1
2021 - 12 - 01
1
2021 - 11 - 22
1
2021 - 11 - 18
1
2021 - 11 - 09
1
2021 - 11 - 08
1
2021 - 10 - 29
1
2021 - 10 - 20
1
2021 - 10 - 06
1
2021 - 09 - 21
1
2021 - 09 - 01
1
2021 - 08 - 24
1
2021 - 08 - 19
2
2021 - 08 - 09
1
2021 - 08 - 04
1
2021 - 08 - 03
1
2021 - 07 - 29
1
2021 - 07 - 21
1
2021 - 07 - 20
1
2021 - 07 - 19
1
2021 - 07 - 06
1
2021 - 06 - 28
1
2021 - 06 - 22
1
2021 - 06 - 09
1
2021 - 06 - 03
1
2021 - 05 - 05
1
2021 - 04 - 28
1
2021 - 04 - 21
1
2021 - 04 - 14
1
2021 - 04 - 07
1
2021 - 03 - 22
1
2021 - 02 - 23
1
2021 - 02 - 03
1
2021 - 02 - 02
1
2021 - 01 - 04
1
2020 - 12 - 31
1
2020 - 12 - 14
1
2020 - 12 - 10
1
Crawled Time
00:00
3
00:20
1
01:00
4
02:00
1
03:00
1
07:00
1
08:00
2
09:00
4
10:00
1
11:00
3
12:00
4
12:20
4
12:30
1
13:00
14
13:20
2
13:30
3
14:00
11
14:15
1
14:20
2
14:30
3
15:00
6
15:20
1
16:00
3
17:00
2
18:00
2
19:00
2
20:00
1
21:00
9
22:00
6
23:00
2
23:07
1
Source
www.adnas.com
1
www.biospace.com
65
www.globenewswire.com
2
www.prnewswire.com
33
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
sector :
Health services
symbols :
Bioc
save search
Whole Genome and Exome Sequencing Market Analysis 2023-2024 and 2027 with Executive and Consultant Guides Featuring llumina, ION, Pacific Biosystems, Roche, SOLiD, Oxford Nanopore Among Others
Published:
2024-03-29
(Crawled : 02:00)
- prnewswire.com
NHIQ
|
$0.341
16.76%
110
|
Information
|
Email alert
Add to watchlist
BDX
|
$234.12
0.42%
0.0%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
NVTA
|
$0.019
0.0%
22M
|
Health Services
|
Email alert
Add to watchlist
BIOC
|
$0.4349
-10.32%
750K
|
Health Services
|
Email alert
Add to watchlist
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
Email alert
Add to watchlist
NH
|
$1.35
-46.64%
-1.48%
0
|
Technology Services
|
Email alert
Add to watchlist
market
In Vitro Diagnostic Tests Market Report, with Profiles of 300+ Companies and Detail on the Top 40
Published:
2023-12-22
(Crawled : 00:00)
- prnewswire.com
RNVA
|
$0.0001
0.0%
140M
|
Professional, Scientific, and T...
|
-99.0%
|
O:
0.0%
H:
0.0%
C:
0.0%
TRIB
|
$1.81
-3.72%
-3.87%
5.7K
|
Health Technology
|
307.98%
|
O:
-6.87%
H:
6.33%
C:
-3.57%
GH
M
|
$16.08
-3.54%
-3.67%
1.9M
|
Health Services
|
-39.96%
|
O:
0.81%
H:
5.38%
C:
4.47%
CDNA
|
$8.32
3.1%
3.0%
500K
|
Health Technology
|
-32.85%
|
O:
-0.17%
H:
4.71%
C:
2.4%
TECH
|
$62.12
-0.15%
-0.14%
910K
|
Health Technology
|
-19.29%
|
O:
0.85%
H:
0.33%
C:
-1.1%
AXDX
|
$0.8201
6.51%
6.1%
38K
|
Health Technology
|
-80.85%
|
O:
0.23%
H:
3.32%
C:
1.41%
companies
diagnostic
market
Delisting of Securities of Genesis Growth Tech Acquisition Corp.; Financial Strategies Acquisition Corp.; Kiromic BioPharma, Inc.; Infinity Pharmaceuticals, Inc.; Molekule Group, Inc.; EBET, Inc.; Shift Technologies, Inc.; Ontrak, Inc.; RVL Pharmaceuticals plc; Biocept, Inc.; Akumin Inc.; Appreciate Holdings, Inc.; Liberty TripAdvisor Holdings, Inc.; Tempo Automation Holdings, Inc.; Medicenna Therapeutics Corp.; RiceBran Technologies; and Acer Therapeutics Inc. from The Nasdaq Stock Market
Published:
2023-11-17
(Crawled : 21:00)
- globenewswire.com
FXCO
|
$11.0
0.91%
2.7K
|
n/a
|
Email alert
Add to watchlist
INFI
|
$0.016
12.5%
1.1M
|
Health Technology
|
Email alert
Add to watchlist
LTRPA
|
$1.37
5.37%
80K
|
Consumer Services
|
Email alert
Add to watchlist
NDAQ
|
$60.35
0.47%
0.46%
3.1M
|
Finance
|
Email alert
Add to watchlist
AKU
|
$0.2887
-0.42%
8.5M
|
Health Services
|
Email alert
Add to watchlist
MDNA
|
$0.157
-0.32%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
MDNAF
|
$1.24
-17.54%
67K
|
n/a
|
Email alert
Add to watchlist
BIOC
|
$0.4349
-10.32%
750K
|
Health Services
|
Email alert
Add to watchlist
RIBT
4
|
$0.17
-12.78%
1.2K
|
Consumer Non-Durables
|
Email alert
Add to watchlist
OTRK
4
|
$0.2524
-8.08%
-8.8%
1.8M
|
Health Services
|
Email alert
Add to watchlist
LTRPB
|
$10.5
-27.62%
53K
|
Consumer Services
|
Email alert
Add to watchlist
RVLP
|
$0.0282
-20.92%
64M
|
Manufacturing
|
Email alert
Add to watchlist
ACER
|
$0.9
-3.61%
420K
|
Health Technology
|
Email alert
Add to watchlist
INFIQ
|
$0.0001
3000.0%
680
|
Manufacturing
|
Email alert
Add to watchlist
SFT
|
$0.1703
-23.66%
180M
|
Finance
|
Email alert
Add to watchlist
KRBP
|
$2.5
-90.21%
830
|
Health Technology
|
Email alert
Add to watchlist
GGAA
|
$21.57
2.1M
|
n/a
|
Email alert
Add to watchlist
tempo
acquisition
pharmaceuticals
liberty
therapeutics
financial
growth
market
Global Biopsy Devices Market Projected to Reach $11.86 Billion by 2027, Fueled by Rising Cancer Incidence and Advanced Diagnostic Procedures
Published:
2023-11-10
(Crawled : 01:00)
- prnewswire.com
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
16.5%
|
O:
-3.09%
H:
0.0%
C:
0.0%
SYK
|
$325.43
-0.62%
0.0%
1.8M
|
Health Technology
|
24.07%
|
O:
0.3%
H:
1.31%
C:
0.72%
MDT
|
$79.48
0.37%
-0.29%
6.7M
|
Health Technology
|
12.83%
|
O:
0.49%
H:
0.57%
C:
0.35%
CNMD
|
$72.64
2.2%
0.0%
500K
|
Health Technology
|
-19.91%
|
O:
0.21%
H:
1.91%
C:
1.65%
CAH
|
$108.19
2.07%
0.0%
1.5M
|
Distribution Services
|
4.24%
|
O:
0.26%
H:
1.46%
C:
1.01%
BSX
|
$67.33
-0.13%
-0.31%
7M
|
Health Technology
|
31.09%
|
O:
0.43%
H:
0.41%
C:
-0.17%
BIO
|
$279.73
-0.46%
0.0%
290K
|
Health Technology
|
-11.08%
|
O:
-0.27%
H:
0.44%
C:
-0.63%
BDX
|
$234.12
0.42%
0.0%
1.3M
|
Health Technology
|
-0.53%
|
O:
0.68%
H:
0.8%
C:
0.35%
A
|
$132.73
0.22%
0.0%
1.3M
|
Health Technology
|
25.71%
|
O:
-1.1%
H:
0.0%
C:
0.0%
ILMN
|
$117.43
0.63%
0.63%
1.4M
|
Health Technology
|
10.57%
|
O:
-12.11%
H:
4.83%
C:
4.63%
CNMD
|
$72.64
2.2%
-1.98%
500K
|
Health Technology
|
-19.91%
|
O:
0.21%
H:
1.91%
C:
1.65%
diagnostic
reach
cancer
global
market
Global Rare Biomarkers Specimen Collection and Stabilization Market Set to Reach $84.18 Billion by 2030, Driven by Expanding Applications in Liquid Biopsy and Cancer Research
Published:
2023-11-02
(Crawled : 09:00)
- prnewswire.com
BIO
|
$279.73
-0.46%
0.0%
290K
|
Health Technology
|
-1.7%
|
O:
1.37%
H:
1.2%
C:
-0.04%
TECH
|
$62.12
-0.15%
-0.14%
910K
|
Health Technology
|
18.74%
|
O:
1.78%
H:
4.05%
C:
3.05%
rare
reach
cancer
research
global
set
biomarkers
market
Precision Medicine Takes Center Stage: Innovative Report Explores the Role of Companion Diagnostics in Transforming Healthcare
Published:
2023-09-22
(Crawled : 22:00)
- prnewswire.com
MLAB
|
$101.19
1.58%
1.55%
27K
|
Health Technology
|
Email alert
Add to watchlist
ANPCF
|
$0.148
641.22%
5K
|
Health Technology
|
Email alert
Add to watchlist
NH
|
$1.35
-46.64%
-1.48%
0
|
Technology Services
|
Email alert
Add to watchlist
BIOC
|
$0.4349
-10.32%
750K
|
Health Services
|
Email alert
Add to watchlist
NVTA
|
$0.019
0.0%
22M
|
Health Services
|
Email alert
Add to watchlist
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
Email alert
Add to watchlist
CSTL
|
$19.28
0.42%
0.41%
130K
|
Health Technology
|
Email alert
Add to watchlist
BDX
|
$234.12
0.42%
0.0%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
NHIQ
|
$0.341
16.76%
110
|
Information
|
Email alert
Add to watchlist
ANPCY
|
$1.98
338.38%
930
|
Manufacturing
|
Email alert
Add to watchlist
TXG
|
$27.92
-3.56%
-3.69%
2M
|
Health Technology
|
Email alert
Add to watchlist
report
companion
diagnostics
Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept’s CNSide™ Assay to Evaluate Patients with Leptomeningeal Metastases
Published:
2023-09-21
(Crawled : 13:30)
- biospace.com/
BIOC
|
$0.4349
-10.32%
750K
|
Health Services
|
-70.61%
|
O:
-4.73%
H:
6.38%
C:
0.71%
trial
Plus Therapeutics Enters into License Agreement for Cerebrospinal Fluid Tumor Cell Enumeration Assay
Published:
2023-09-08
(Crawled : 11:00)
- globenewswire.com
PSTV
|
$1.67
-1.27%
-1.28%
25K
|
Health Technology
|
-43.1%
|
O:
6.4%
H:
1.58%
C:
-56.33%
BIOC
|
$0.4349
-10.32%
750K
|
Health Services
|
-48.25%
|
O:
83.25%
H:
0.0%
C:
0.0%
license
cell
tumor
therapeutics
plus
agreement
APDN Appoints Beverly Wolgast as Executive Director of Quality and cGMP Programs
Published:
2023-09-06
(Crawled : 14:00)
- adnas.com
BIOC
|
$0.4349
-10.32%
750K
|
Health Services
|
-47.03%
|
O:
4.38%
H:
2.21%
C:
-3.03%
APDN
|
$0.3396
0.59%
0.59%
85K
|
Commercial Services
|
-73.31%
|
O:
-1.55%
H:
2.36%
C:
0.0%
Biocept to Participate in the H.C. Wainwright Global Investment Conference
Published:
2023-09-05
(Crawled : 14:00)
- biospace.com/
BIOC
|
$0.4349
-10.32%
750K
|
Health Services
|
-51.68%
|
O:
-0.89%
H:
1.67%
C:
-7.96%
conference
global
Biocept to Hold Business Update Conference Call on August 30, 2023
Published:
2023-08-25
(Crawled : 17:00)
- biospace.com/
BIOC
|
$0.4349
-10.32%
750K
|
Health Services
|
-53.73%
|
O:
-3.18%
H:
0.0%
C:
0.0%
conference
business
update
Biocept’s CNSide™ Cerebrospinal Fluid Assay Featured in Two Oral Presentations at the 2023 SNO/ASCO CNS Cancer Conference
Published:
2023-08-14
(Crawled : 12:20)
- biospace.com/
BIOC
|
$0.4349
-10.32%
750K
|
Health Services
|
-59.73%
|
O:
3.7%
H:
2.68%
C:
-1.79%
conference
cancer
Biocept Names Antonino Morales as President and Chief Executive Officer
Published:
2023-06-20
(Crawled : 21:00)
- biospace.com/
BIOC
|
$0.4349
-10.32%
750K
|
Health Services
|
-77.47%
|
O:
-0.52%
H:
5.73%
C:
5.73%
Biocept to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 20, 2023
Published:
2023-06-14
(Crawled : 22:00)
- biospace.com/
BIOC
|
$0.4349
-10.32%
750K
|
Health Services
|
-75.08%
|
O:
-0.29%
H:
1.72%
C:
0.57%
conference
group
Scientific Poster Presented at the 2023 ASCO Annual Meeting Highlights Performance of Biocept’s CNSide™ Versus Cytology
Published:
2023-06-05
(Crawled : 13:20)
- biospace.com/
BIOC
|
$0.4349
-10.32%
750K
|
Health Services
|
-79.58%
|
O:
1.41%
H:
1.38%
C:
-2.31%
asco
meeting
Biocept Announces Pricing of $5.0 Million Underwritten Public Offering
Published:
2023-05-25
(Crawled : 08:00)
- biospace.com/
BIOC
|
$0.4349
-10.32%
750K
|
Health Services
|
-89.77%
|
O:
-43.06%
H:
3.31%
C:
-4.13%
offering
Biocept Announces One-for-Thirty Reverse Stock Split
Published:
2023-05-17
(Crawled : 12:20)
- biospace.com/
BIOC
|
$0.4349
-10.32%
750K
|
Health Services
|
106.8%
|
O:
2852.92%
H:
4.24%
C:
-13.2%
Biocept Reports First Quarter 2023 Financial Results
Published:
2023-05-10
(Crawled : 21:00)
- biospace.com/
BIOC
|
$0.4349
-10.32%
750K
|
Health Services
|
62.88%
|
O:
1.46%
H:
0.04%
C:
-3.4%
financial
results
Biocept Reports 2022 Financial Results
Published:
2023-04-17
(Crawled : 22:00)
- biospace.com/
BIOC
|
$0.4349
-10.32%
750K
|
Health Services
|
24.61%
|
O:
-2.12%
H:
5.39%
C:
1.08%
financial
results
Enrollment Begins in FORESEE Clinical Trial Using Biocept’s CNSide™ to Evaluate Patients with Leptomeningeal Metastases
Published:
2023-03-24
(Crawled : 13:00)
- biospace.com/
BIOC
|
$0.4349
-10.32%
750K
|
Health Services
|
44.97%
|
O:
0.0%
H:
1.67%
C:
-2.67%
trial
← Previous
1
2
3
4
5
6
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.